Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 9,060.00
-90.00 (-0.98%)
Apr 29, 2026, 12:10 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 107.81 billion as of April 28, 2026. Its market cap has decreased by -9.83% in one year.
Market Cap
107.81B
Enterprise Value
89.74B
Revenue
370.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
9,060.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 107.81B, an increase of 1.47%. That is a compound annual growth rate of 1.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 107.81B | -6.44% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 258.32B |
| Macrogen | 185.93B |
| MedPacto | 183.71B |
| Vaxcell-Bio Therapeutics | 181.17B |
| ENCell | 176.61B |
| Amicogen | 131.18B |
| iNtRON Biotechnology | 120.13B |
| IMB Dx | 102.61B |